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Martin Kaefer 
The technique of seromuscular bladder augmentation (SMBA), as first described experimentally 
by Shoemaker [1] and later popularized in human subjects by Dewan [2], continues to hold great interest 
among urologists as a means of providing an augmentation substrate that avoids incorporation of 
absorptive epithelium. Yet the widespread acceptance of this technique has remained elusive, due to lack 
of evidence that a significant decrease in complication rate exists that would warrant the increased 
technical challenges and length of the operative procedure. To this end, the authors of the present paper 
seek to document differences between augmentation with unaltered ileal and demucosalized colonic 
segments. 
While this report lends further support to SMBA being a safe and effective technique, the results 
presented show no advantage over standard enterocystoplasty. The small number of subjects in the 
SMBA group (n = 10) does not provide sufficient power to demonstrate a statistically significant 
difference in the categories investigated. The authors point to more stones being formed in the 
ileocystoplasty group (8/30 or 27%) relative to the SMBA cohort. However, from the results section, one 
gleans that only five of the stones were of significant size to require surgical intervention. If only 5/30 
(17%) patients had significant stones, the calculated P -value between the SMBA and ileocystoplasty 
groups would be P = 0.17. Compared to the historical results of Jednak, et al, who found that 6% of his 
cohort of 32 SMBA patients developed calculi [3], the difference between the two groups becomes even 
smaller. 
Despite the fact that significant differences in stone formation cannot be demonstrated, I remain a 
strong supporter of this and other alternatives to standard bladder augmentation. The theory behind the 
2 
 
present procedure is sound and worthy of continued pursuit. Perhaps with time we will find that the 
difference in stone incidence is statistically significant or the probability of malignant transformation is 
less. However, if we are to come to any meaningful conclusions that the demucosalization technique is 
equally good at achieving an increase in bladder capacity while limiting complications, it would be 
beneficial for future studies to focus not on differences between two different bowel segments 
(demucosalized colon versus unaltered ilium) but rather between two segments of equal composition 
(demucosalized colon versus unaltered colon). 
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